Pioneer 5 of 21 · 1899-1975
Percy Julian
Contribution. First to synthesize physostigmine, a glaucoma drug, in 1935. He then pioneered large-scale production of steroid hormones, including progesterone and testosterone, from soybean sterols. He received more than 130 patents.
Factor coverage
Favorable entries (helped or barrier absent) and adverse entries (barrier or not overcome) by factor. Factor tags are this site's classification.
Barriers faced
| Factors | Statement |
|---|---|
| Educational Societal Economic | Born in Montgomery, Alabama, the grandson of enslaved people. Montgomery had no public high school for Black students, so he entered DePauw University inadequately prepared and started as a probationary student. |
| Societal Cultural | After he earned a master's degree from Harvard in 1923, Harvard denied him the teaching assistantship needed to continue to a doctorate, reportedly out of concern that white students would resent a Black instructor. |
| Societal Cultural | After his physostigmine breakthrough, DePauw refused him a permanent faculty position. At the time, American colleges were not prepared to have a Black person teach white students. |
| Societal Social Cultural | When his family moved to the white suburb of Oak Park, Illinois, around 1950, their home was attacked, including a firebombing. The family stayed. |
What helped
| Factors | Statement |
|---|---|
| Social | A mentor. DePauw chemistry professor William Blanchard encouraged him toward research and later brought him back to DePauw as a research fellow. |
| Educational Economic | Fellowships and study abroad. A fellowship took him to Harvard, and he earned his doctorate at the University of Vienna in 1931, where he began working with plant compounds. |
| Social | A collaborator. Josef Pikl, a fellow student from Vienna, joined him at DePauw. Together they completed the physostigmine synthesis. |
| Economic Societal | A private-sector path. When universities closed their doors, the Glidden Company hired him in 1936 to direct research in its soybean division. In 1953 he founded Julian Laboratories, which he sold in 1961 for more than $2 million. |
Not overcome
Pattern summary
| Element | In this case |
|---|---|
| Door-opener | Blanchard |
| Knowledge source | DePauw, Harvard, Vienna |
| Institutional support | DePauw fellowship, Glidden |
| Built on recent work | Plant chemistry learned in Vienna |
| Setback overcome | Segregated schooling, Harvard's refusal |
| Barrier not overcome | Denied a professorship |
Sources
- American Chemical Society: Percy Lavon Julian
- American Chemical Society: Percy L. Julian and the synthesis of physostigmine
- PBS NOVA: Who was Percy Julian?
- U.S. Patent and Trademark Office: Surmounting the insurmountable (Percy Julian)
- National Endowment for the Humanities: Percy Julian (2007)
- Wednesday Journal: Oak Park library features a new Percy Julian exhibit (2022)
Also relevant: Bell, A., Chetty, R., Jaravel, X., Petkova, N., & Van Reenen, J. (2019). Who becomes an inventor in America? Quarterly Journal of Economics, 134(2), 647-713. All references